Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Posters by Session

Select Session

Thumbnail for Defining the “Frailty Cliff": A Restricted Cubic Spline Meta-Analysis of AI-Derived Continuous Mesenteric Adiposity and Skeletal Muscle Index on Induction Mortality in Acute Myeloid Leukemia

AML - 1473

Defining the “Frailty Cliff": A Restricted Cubic Spline Meta-Analysis of AI-Derived Continuous Mesenteric Adiposity and Skeletal Muscle Index on Induction Mortality in Acute Myeloid Leukemia

Iman Khan

Poster Presenter: Iman Khan

Thumbnail for Frontline Systemic Therapeutic Patterns and Outcomes in Rosai-Dorfman Disease: A Multicenter Retrospective Analysis

MPN - 1474

Frontline Systemic Therapeutic Patterns and Outcomes in Rosai-Dorfman Disease: A Multicenter Retrospective Analysis

Aishwarya Pradeep

Poster Presenter: Aishwarya Pradeep

Previous 1...118 119 120 121 122 123 124...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Lower-Intensity Versus Intensive Therapy in Older Adults With Newly Diagnosed AML: A Systematic Review and Meta-Analysis

AML - 1475

Lower-Intensity Versus Intensive Therapy in Older Adults With Newly Diagnosed AML: A Systematic Review and Meta-Analysis

Musa Kiyani

Poster Presenter: Musa Kiyani

Thumbnail for Differential Impact of Allogeneic Stem Cell Transplantation by TP53 Mutational Status in High-Risk Myeloid Neoplasms With Complex or Monosomal Karyotype

AML - 1476

Differential Impact of Allogeneic Stem Cell Transplantation by TP53 Mutational Status in High-Risk Myeloid Neoplasms With Complex or Monosomal Karyotype

Paloma Resende

Poster Presenter: Paloma Resende

Thumbnail for Second Primary Malignancies in Cutaneous T-Cell Lymphoma: A Retrospective Population-Based Analysis

TCL - 1477

Second Primary Malignancies in Cutaneous T-Cell Lymphoma: A Retrospective Population-Based Analysis

Michael Asare

Poster Presenter: Michael Asare

Thumbnail for Early Cytarabine Escalation Does Not Improve Short-Term Outcomes Compared With Hydroxyurea-Only Cytoreduction in Hyperleukocytic Acute Myeloid Leukemia: A Real-World Propensity-Matched Analysis

AML - 1478

Early Cytarabine Escalation Does Not Improve Short-Term Outcomes Compared With Hydroxyurea-Only Cytoreduction in Hyperleukocytic Acute Myeloid Leukemia: A Real-World Propensity-Matched Analysis

Akshay Aluri

Poster Presenter: Akshay Aluri

Thumbnail for Complication Burden Across Age Groups in Venetoclax-Based Acute Myeloid Leukemia Hospitalizations: A National Inpatient Sample Study

CT - 1479

Complication Burden Across Age Groups in Venetoclax-Based Acute Myeloid Leukemia Hospitalizations: A National Inpatient Sample Study

Aishwarya Ramesh

Poster Presenter: Aishwarya Ramesh

Thumbnail for Acute Kidney Injury as a Risk Stratification Tool in Multiple Myeloma: Insights from a Nationwide Analysis of Mortality and 30-Day Readmission

MM - 1482

Acute Kidney Injury as a Risk Stratification Tool in Multiple Myeloma: Insights from a Nationwide Analysis of Mortality and 30-Day Readmission

Rushi Shah

Poster Presenter: Rushi Shah

Thumbnail for Multi-Hit TET2 Inactivation Identifies a High-Risk Subgroup Assigned to Favorable or Intermediate Categories by the HARMONY Framework in NPM1-Mutated AML

AML - 1483

Multi-Hit TET2 Inactivation Identifies a High-Risk Subgroup Assigned to Favorable or Intermediate Categories by the HARMONY Framework in NPM1-Mutated AML

Paloma Resende

Poster Presenter: Paloma Resende

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors